# FDA recall D-0649-2016

> **Pfizer Inc.** · Class II · drug recall initiated 2016-01-11.

## Product

Lyrica (pregabalin) capsules, 75 mg, 90-count bottle, Rx only, Distributed by: Parke-Davis, Division of Pfizer Inc., NY, NY 10017, NDC 0071-1014-68

## Reason for recall

FAILED TABLET/CAPSULE SPECIFICATIONS: Firm is recalling specific lots of pregabalin capsules due to the potential presence of deformed or damaged capsules.

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-0649-2016
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2016-01-11
- **Report date:** 2016-02-10
- **Termination date:** 2017-04-24

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0649-2016

## Citation

> AI Analytics. FDA recall D-0649-2016. Retrieved 2026-05-24 from https://api.ai-analytics.org/recall/D-0649-2016. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*